1![05-AUG:10 LUNG ACCRUAL REPORT - Open and Recently Closed Studies SWOG/ Support STUDY 05-AUG:10 LUNG ACCRUAL REPORT - Open and Recently Closed Studies SWOG/ Support STUDY](https://www.pdfsearch.io/img/eb24d67a650195100969a792c419bbad.jpg) | Add to Reading ListSource URL: www.swogstat.orgLanguage: English - Date: 2016-08-19 21:10:12
|
---|
2![Blood Testing for EML4-ALK Fusion Transcripts in Non-Small Cell Lung Cancer Patients by ddPCR: A CLIA Lab Experience Hestia Mellert, PhD April 17th, 2016 Blood Testing for EML4-ALK Fusion Transcripts in Non-Small Cell Lung Cancer Patients by ddPCR: A CLIA Lab Experience Hestia Mellert, PhD April 17th, 2016](https://www.pdfsearch.io/img/ad0b1fe9d1913139a729d81243dba24b.jpg) | Add to Reading ListSource URL: www.biodesix.comLanguage: English - Date: 2016-05-02 01:40:22
|
---|
3![th 6 Meeting of the European Research Initiative on ALK-related Malignancies th 6 Meeting of the European Research Initiative on ALK-related Malignancies](https://www.pdfsearch.io/img/d70c991b294af37869c7fe0810c71865.jpg) | Add to Reading ListSource URL: erialcl.netLanguage: English - Date: 2015-09-30 10:24:57
|
---|
4![Microsoft PowerPoint - Corporate Presentation May 2013 Microsoft PowerPoint - Corporate Presentation May 2013](https://www.pdfsearch.io/img/a56d3f67a0a8d68e0a4c7050c36f370e.jpg) | Add to Reading ListSource URL: erialcl.netLanguage: English - Date: 2015-09-29 07:01:25
|
---|
5![3rd Meeting of the European Research Initiative on ALCL Punting on the River Cam with the chapel of King’s College in the background 3rd Meeting of the European Research Initiative on ALCL Punting on the River Cam with the chapel of King’s College in the background](https://www.pdfsearch.io/img/b235bde0cd2eb7d54d0b0c7d2b2e44a2.jpg) | Add to Reading ListSource URL: erialcl.netLanguage: English - Date: 2015-09-29 07:00:59
|
---|
6![Early Stage researcher (ESR) PhD Projects ESR 1 Investigation of the nuclear functions of ALK Duration: 3 years Start: before August 2016 Early Stage researcher (ESR) PhD Projects ESR 1 Investigation of the nuclear functions of ALK Duration: 3 years Start: before August 2016](https://www.pdfsearch.io/img/568e558be7ae08c3016e116852dc960b.jpg) | Add to Reading ListSource URL: alkatras.erialcl.netLanguage: English - Date: 2016-04-15 08:51:39
|
---|
7![Open Up More Treatment Possibilities For Your Patients
About FoundationOne® FoundationOne is a validated comprehensive Genomic Profile that interrogates the entire coding sequence of 315 cancer-related genes plus selec Open Up More Treatment Possibilities For Your Patients
About FoundationOne® FoundationOne is a validated comprehensive Genomic Profile that interrogates the entire coding sequence of 315 cancer-related genes plus selec](https://www.pdfsearch.io/img/0d9f926d14ef5a9a98b224c2d7f3e45e.jpg) | Add to Reading ListSource URL: www.foundationmedicine.comLanguage: English - Date: 2015-07-29 10:38:28
|
---|
8![Phase (Ph) 1/2a study of TSR-011, a potent inhibitor of ALK and TRK, in advanced solid tumors including crizotinib-resistant ALK positive non-small cell lung cancer PosterHendrik-Tobias Arkenau,1 Jasgit C. Sachdev Phase (Ph) 1/2a study of TSR-011, a potent inhibitor of ALK and TRK, in advanced solid tumors including crizotinib-resistant ALK positive non-small cell lung cancer PosterHendrik-Tobias Arkenau,1 Jasgit C. Sachdev](https://www.pdfsearch.io/img/606f3978d13d0662f8562eed2a3c8d8a.jpg) | Add to Reading ListSource URL: www.tesarobio.comLanguage: English - Date: 2015-06-03 16:42:55
|
---|
9![SPECIAL AUTHORIZATION REQUEST FOR COVERAGE OF HIGH COST CANCER DRUGS (Filgrastim, Capecitabine, Imatinib, Dasatinib, Erolotinib, Sunitinib, Pazopanib, Fludarabine, Sorafenib, Crizotinib, Tretinoin, Nilotinib, Temozolomid SPECIAL AUTHORIZATION REQUEST FOR COVERAGE OF HIGH COST CANCER DRUGS (Filgrastim, Capecitabine, Imatinib, Dasatinib, Erolotinib, Sunitinib, Pazopanib, Fludarabine, Sorafenib, Crizotinib, Tretinoin, Nilotinib, Temozolomid](https://www.pdfsearch.io/img/d38a11d7833322951d43531e26f29ea8.jpg) | Add to Reading ListSource URL: www.gov.pe.caLanguage: English - Date: 2015-04-28 07:44:05
|
---|
10![Correlation of plasma crizotinib trough concentration with adverse events in patients with anaplastic lymphoma kinase positive non-small-cell lung cancer Correlation of plasma crizotinib trough concentration with adverse events in patients with anaplastic lymphoma kinase positive non-small-cell lung cancer](https://www.pdfsearch.io/img/01727136d2e1ce243edf690382927910.jpg) | Add to Reading ListSource URL: www.jphcs.netLanguage: English |
---|